Frank McCormick - Publications

Affiliations: 
Cell Biology University of California, San Francisco, San Francisco, CA 
Area:
Cell Biology, Virology Biology, Oncology

116 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang VE, Hemmati G, Martins MM, Maynard A, Kuhn J, Galeas J, Donnella HJ, Kaushik S, Ku A, Dumont S, ... ... McCormick F, et al. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nature Medicine. PMID 30478424 DOI: 10.1038/s41591-018-0264-7  0.56
2016 Gerhard DS, Clemons PA, Shamji AF, Hon C, Wagner BK, Schreiber SL, Krasnitz A, Sordella R, Sander C, Lowe SW, Powers S, Smith K, Aburi M, Iavarone A, Lasorella A, ... ... McCormick F, et al. Transforming Big Data into cancer-relevant insight: An initial, multi-tier approach to assess reproducibility and relevance. Molecular Cancer Research : McR. PMID 27401613 DOI: 10.1158/1541-7786.MCR-16-0090  0.56
2016 McCormick F. K-Ras protein as a drug target. Journal of Molecular Medicine (Berlin, Germany). PMID 26960760 DOI: 10.1007/s00109-016-1382-7  0.56
2015 Wang MT, Holderfield M, Galeas J, Delrosario R, To MD, Balmain A, McCormick F. K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling. Cell. 163: 1237-51. PMID 26590425 DOI: 10.1016/j.cell.2015.10.041  0.56
2015 Nan X, Tamgüney TM, Collisson EA, Lin LJ, Pitt C, Galeas J, Lewis S, Gray JW, McCormick F, Chu S. Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway. Proceedings of the National Academy of Sciences of the United States of America. 112: 7996-8001. PMID 26080442 DOI: 10.1073/pnas.1509123112  0.56
2015 Fujita-Sato S, Galeas J, Truitt M, Pitt C, Urisman A, Bandyopadhyay S, Ruggero D, McCormick F. Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth Conditions. Cancer Research. 75: 2851-62. PMID 25977330 DOI: 10.1158/0008-5472.CAN-14-1623  0.56
2015 McCormick F. KRAS as a Therapeutic Target. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1797-801. PMID 25878360 DOI: 10.1158/1078-0432.CCR-14-2662  0.56
2015 McCormick F. The potential of targeting Ras proteins in lung cancer. Expert Opinion On Therapeutic Targets. 19: 451-4. PMID 25558943 DOI: 10.1517/14728222.2014.1000304  0.56
2015 Martins MM, Zhou AY, Corella A, Horiuchi D, Yau C, Rakshandehroo T, Gordan JD, Levin RS, Johnson J, Jascur J, Shales M, Sorrentino A, Cheah J, Clemons PA, Shamji AF, ... ... McCormick F, et al. Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map. Cancer Discovery. 5: 154-67. PMID 25501949 DOI: 10.1158/2159-8290.CD-14-0552  0.56
2014 Sos ML, Levin RS, Gordan JD, Oses-Prieto JA, Webber JT, Salt M, Hann B, Burlingame AL, McCormick F, Bandyopadhyay S, Shokat KM. Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors. Cell Reports. 8: 1037-48. PMID 25127139 DOI: 10.1016/j.celrep.2014.07.010  0.56
2014 Yuan TL, Fellmann C, Lee CS, Ritchie CD, Thapar V, Lee LC, Hsu DJ, Grace D, Carver JO, Zuber J, Luo J, McCormick F, Lowe SW. Development of siRNA payloads to target KRAS-mutant cancer. Cancer Discovery. 4: 1182-97. PMID 25100204 DOI: 10.1158/2159-8290.CD-13-0900  0.56
2014 Thai M, Graham NA, Braas D, Nehil M, Komisopoulou E, Kurdistani SK, McCormick F, Graeber TG, Christofk HR. Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication. Cell Metabolism. 19: 694-701. PMID 24703700 DOI: 10.1016/j.cmet.2014.03.009  0.56
2014 Stephen AG, Esposito D, Bagni RK, McCormick F. Dragging ras back in the ring. Cancer Cell. 25: 272-81. PMID 24651010 DOI: 10.1016/j.ccr.2014.02.017  0.56
2014 Kashiyama T, Oda K, Ikeda Y, Shiose Y, Hirota Y, Inaba K, Makii C, Kurikawa R, Miyasaka A, Koso T, Fukuda T, Tanikawa M, Shoji K, Sone K, Arimoto T, ... ... McCormick F, et al. Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423. Plos One. 9: e87220. PMID 24504419 DOI: 10.1371/journal.pone.0087220  0.56
2014 Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, ... ... McCormick F, et al. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. American Journal of Medical Genetics. Part A. 164: 563-78. PMID 24443315 DOI: 10.1002/ajmg.a.36312  0.56
2014 Salt MB, Bandyopadhyay S, McCormick F. Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation. Cancer Discovery. 4: 186-99. PMID 24302555 DOI: 10.1158/2159-8290.CD-13-0520  0.56
2014 Nehil M, Paquette J, Tokuyasu T, McCormick F. High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A. Oncogene. 33: 5151-62. PMID 24213571 DOI: 10.1038/onc.2013.459  0.56
2013 Yuan TL, McCormick F. Killing tumors by keeping ras and PI3' kinase apart. Cancer Cell. 24: 562-3. PMID 24229705 DOI: 10.1016/j.ccr.2013.10.015  0.56
2013 Holderfield M, Merritt H, Chan J, Wallroth M, Tandeske L, Zhai H, Tellew J, Hardy S, Hekmat-Nejad M, Stuart DD, McCormick F, Nagel TE. RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation. Cancer Cell. 23: 594-602. PMID 23680146 DOI: 10.1016/j.ccr.2013.03.033  0.56
2013 Young A, Lou D, McCormick F. Oncogenic and wild-type Ras play divergent roles in the regulation of mitogen-activated protein kinase signaling. Cancer Discovery. 3: 112-23. PMID 23103856 DOI: 10.1158/2159-8290.CD-12-0231  0.56
2012 Shoji K, Oda K, Kashiyama T, Ikeda Y, Nakagawa S, Sone K, Miyamoto Y, Hiraike H, Tanikawa M, Miyasaka A, Koso T, Matsumoto Y, Wada-Hiraike O, Kawana K, Kuramoto H, ... McCormick F, et al. Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas. Plos One. 7: e37431. PMID 22662154 DOI: 10.1371/journal.pone.0037431  0.56
2011 Gysin S, Salt M, Young A, McCormick F. Therapeutic strategies for targeting ras proteins. Genes & Cancer. 2: 359-72. PMID 21779505 DOI: 10.1177/1947601911412376  0.56
2011 Rauen KA, Banerjee A, Bishop WR, Lauchle JO, McCormick F, McMahon M, Melese T, Munster PN, Nadaf S, Packer RJ, Sebolt-Leopold J, Viskochil DH. Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 157: 136-46. PMID 21495172 DOI: 10.1002/ajmg.c.30294  0.56
2011 McCormick F. Cancer therapy based on oncogene addiction. Journal of Surgical Oncology. 103: 464-7. PMID 21480237 DOI: 10.1002/jso.21749  0.56
2011 McCormick F. Mutant onco-proteins as drug targets: successes, failures, and future prospects. Current Opinion in Genetics & Development. 21: 29-33. PMID 21236660 DOI: 10.1016/j.gde.2010.12.002  0.56
2010 Harris TJ, McCormick F. The molecular pathology of cancer. Nature Reviews. Clinical Oncology. 7: 251-65. PMID 20351699 DOI: 10.1038/nrclinonc.2010.41  0.56
2010 Phan VT, Ding VW, Li F, Chalkley RJ, Burlingame A, McCormick F. The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans. Molecular and Cellular Biology. 30: 2264-79. PMID 20160012 DOI: 10.1128/MCB.01450-08  0.56
2010 McCormick F. How blocking Raf activates the MAPK pathway. Pigment Cell & Melanoma Research. 23: 187-9. PMID 20128874 DOI: 10.1111/j.1755-148X.2010.00680.x  0.56
2010 Kissil JL, Blakeley JO, Ferner RE, Huson SM, Kalamarides M, Mautner VF, McCormick F, Morrison H, Packer R, Ramesh V, Ratner N, Rauen KA, Stevenson DA, Hunter-Schaedle K, North K. What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers. American Journal of Medical Genetics. Part A. 152: 269-83. PMID 20082461 DOI: 10.1002/ajmg.a.33189  0.56
2008 McCormick F, Korn WM. Gene Therapy and Oncolytic Viruses The Molecular Basis of Cancer. 679-690. DOI: 10.1016/B978-141603703-3.10056-1  0.56
2007 McCormick F. Success and failure on the ras pathway Cancer Biology and Therapy. 6: 1654-1659. PMID 18245956  0.56
2006 Lee SH, McCormick F. p97/DAP5 is a ribosome-associated factor that facilitates protein synthesis and cell proliferation by modulating the synthesis of cell cycle proteins Embo Journal. 25: 4008-4019. PMID 16932749 DOI: 10.1038/sj.emboj.7601268  0.56
2006 Rodriguez-Viciana P, McCormick F. Ras ubiquitination: Coupling spatial sorting and signal transmission Cancer Cell. 9: 243-244. PMID 16616329 DOI: 10.1016/j.ccr.2006.03.025  0.56
2005 Rodriguez-Viciana P, McCormick F. Characterization of Interactions Between Ras Family GTPases and Their Effectors Methods in Enzymology. 407: 187-194. PMID 16757324 DOI: 10.1016/S0076-6879(05)07016-3  0.56
2005 McCormick F. Future prospects for oncolytic therapy Oncogene. 24: 7817-7819. PMID 16299540 DOI: 10.1038/sj.onc.1209064  0.56
2005 Rodriguez-Viciana P, McCormick F. RalGDS comes of age Cancer Cell. 7: 205-206. PMID 15766656 DOI: 10.1016/j.ccr.2005.02.012  0.56
2005 Lee SH, McCormick F. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells Journal of Molecular Medicine. 83: 296-307. PMID 15605273 DOI: 10.1007/s00109-004-0611-7  0.56
2005 McCormick F. Novel approaches to p53-based therapy: ONYX-015 25 Years of P53 Research. 421-429. DOI: 10.1007/978-1-4020-2922-6_19  0.56
2004 McCormick F. Survival pathways meet their end Nature. 428: 267-269. PMID 15029179 DOI: 10.1038/428267a  0.56
2003 McCormick F. Cancer-specific viruses and the development of ONYX-015 Cancer Biology &Amp; Therapy. 2. PMID 14508094  0.56
2003 Tetsu O, McCormick F. Proliferation of cancer cells despite CDK2 inhibition Cancer Cell. 3: 233-245. PMID 12676582 DOI: 10.1016/S1535-6108(03)00053-9  0.56
2003 McCormick F, Shannon KM. Oncogenes and cell proliferation - Insights from inherited predispositions and mouse models: Editorial overview Current Opinion in Genetics and Development. 13: 3-5. DOI: 10.1016/S0959-437X(03)00003-0  0.56
2002 Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2: 103-12. PMID 12204530 DOI: 10.1016/S1535-6108(02)00102-2  0.56
2002 Sabbatini P, Mccormick F. MDMX inhibits the p300/CBP-mediated acetylation of p53 Dna and Cell Biology. 21: 519-525. PMID 12162806 DOI: 10.1089/104454902320219077  0.56
2001 McCormick F. Cancer gene therapy: Fringe or cutting edge? Nature Reviews Cancer. 1: 130-141. PMID 11905804  0.56
2001 Wakita K, McCormick F, Tetsu O. Method for screening ecdysone-inducible stable cell lines Biotechniques. 31: 414-418. PMID 11515378  0.56
2001 McCormick F. New-age drug meets resistance Nature. 412: 281-282. PMID 11460142 DOI: 10.1038/35085665  0.56
2001 Park JW, McCormick F. ErbB receptors and ras: Upstream, downstream? Cancer Journal. 7: 178-180. PMID 11419025  0.56
2001 Chen RH, McCormick F. Selective targeting to the hyperactive β-catenin/T-cell factor pathway in colon cancer cells Cancer Research. 61: 4445-4449. PMID 11389074  0.56
2001 Wakita K, Tetsu O, McCormick F. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics Cancer Research. 61: 854-858. PMID 11221869  0.56
2000 McCormick F. ONYX-015 selectivity and the p14ARF pathway Oncogene. 19: 6670-6672. PMID 11426653 DOI: 10.1038/sj.onc.1204096  0.56
2000 McCormick F. Interactions between adenovirus proteins and the p53 pathway: The development of ONYX-015 Seminars in Cancer Biology. 10: 453-459. PMID 11170867 DOI: 10.1006/scbi.2000.0336  0.56
2000 McCormick F. Small-molecule inhibitors of cell signaling Current Opinion in Biotechnology. 11: 593-597. PMID 11102795 DOI: 10.1016/S0958-1669(00)00149-X  0.56
2000 Ding VW, Chen RH, McCormick F. Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling Journal of Biological Chemistry. 275: 32475-32481. PMID 10913153  0.56
1999 Sabbatini P, McCormick F. Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53- mediated, transcriptionally dependent apoptosis Journal of Biological Chemistry. 274: 24263-24269. PMID 10446202 DOI: 10.1074/jbc.274.34.24263  0.56
1999 McCormick F. Cancer therapy based on p53 Cancer Journal From Scientific American. 5: 139-144. PMID 10367167  0.56
1999 Chardin P, McCormick F. Brefeldin A: The advantage of being uncompetitive Cell. 97: 153-155. PMID 10219235  0.56
1999 Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells Nature. 398: 422-426. PMID 10201372 DOI: 10.1038/18884  0.56
1999 Brugge JS, McCormick F. Cell regulation intracellular networking Current Opinion in Cell Biology. 11: 173-176. DOI: 10.1016/S0955-0674(99)80022-2  0.56
1999 McCormick F. Signalling networks that cause cancer Trends in Genetics. 15. DOI: 10.1016/S0168-9525(99)01892-2  0.56
1998 Kirn D, Hermiston T, McCormick F. ONYX-015: Clinical data are encouraging [1] Nature Medicine. 4: 1341-1342. PMID 9846551 DOI: 10.1038/3902  0.56
1998 McCormick F. Going for the GAP Current Biology : Cb. 8. PMID 9768349  0.56
1998 McCormick F. Why Ras needs Rho Nature. 394: 220-221. PMID 9685153 DOI: 10.1038/28268  0.56
1997 McCormick F. The superfamily of Ras-related GTPases Japanese Journal of Cancer Research : Gann. 88. PMID 9310130  0.56
1997 Stokoe D, McCormick F. Activation of c-Raf-1 by Ras and Src through different mechanisms: Activation in vivo and in vitro Embo Journal. 16: 2384-2396. PMID 9171352 DOI: 10.1093/emboj/16.9.2384  0.56
1997 McCormick F, Wood DA. The role of p53 in virally associated tumors [3] Trends in Microbiology. 5: 181-182. PMID 9160505 DOI: 10.1016/S0966-842X(97)85013-5  0.56
1997 Katz ME, McCormick F. Signal transduction from multiple Ras effectors Current Opinion in Genetics and Development. 7: 75-79. PMID 9024640 DOI: 10.1016/S0959-437X(97)80112-8  0.56
1996 Kirn DH, McCormick F. Replicating viruses as selective cancer therapeutics Molecular Medicine Today. 2: 519-527. PMID 9015793 DOI: 10.1016/S1357-4310(97)81456-6  0.56
1996 Cook SJ, McCormick F. Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. The Biochemical Journal. 320: 237-45. PMID 8947493  0.56
1996 McCormick F, Wittinghofer A. Interactions between ras proteins and their effectors Current Opinion in Biotechnology. 7: 449-456. PMID 8768906 DOI: 10.1016/S0958-1669(96)80123-6  0.56
1996 McCormick F. Ras biology in atomic detail Nature Structural Biology. 3: 653-655. PMID 8756317 DOI: 10.1038/nsb0896-653  0.56
1996 Porfiri E, McCormick F. Regulation of epidermal growth factor receptor signaling by phosphorylation of the Ras exchange factor hSOS1 Journal of Biological Chemistry. 271: 5871-5877. PMID 8621459 DOI: 10.1074/jbc.271.10.5871  0.56
1995 McCormick F. Ras-related proteins in signal transduction and growth control Molecular Reproduction and Development. 42: 500-506. PMID 8607982 DOI: 10.1002/mrd.1080420419  0.56
1995 Bollag G, McCormick F. Purification of recombinant Ras GTPase-activating proteins Methods in Enzymology. 255: 21-30. PMID 8524104 DOI: 10.1016/S0076-6879(95)55005-4  0.56
1995 Bollag G, McCormick F. Intrinsic and GTPase-activating protein-stimulated Ras GTPase assays Methods in Enzymology. 255: 161-170. PMID 8524100 DOI: 10.1016/S0076-6879(95)55020-8  0.56
1995 McCormick F. Ras signaling and NF1 Current Opinion in Genetics and Development. 5: 51-55. PMID 7749326 DOI: 10.1016/S0959-437X(95)90053-5  0.56
1995 Braselmann S, McCormick F. BCR and RAF form a complex in vivo via 14-3-3 proteins Embo Journal. 14: 4839-4848. PMID 7588613  0.56
1995 Spaargaren M, Bischoff JR, McCormick F. Signal transduction by Ras-like GTPases: A potential target for anticancer drugs Gene Expression. 4: 345-356. PMID 7549466  0.56
1995 McCormick F, Wierenga W. Pharmaceutical biotechnology Current Opinion in Biotechnology. 6: 621-623. DOI: 10.1016/0958-1669(95)80102-2  0.56
1994 McCormick F, Myers P. From genetics to chemistry: tumor suppressor genes and drug discovery Chemistry and Biology. 1: 7-9. PMID 9383365 DOI: 10.1016/1074-5521(94)90035-3  0.56
1994 Cook S, McCormick F. Ras blooms on sterile ground Nature. 369: 361-362. PMID 8196762  0.56
1994 McCormick F. Activators and effectors of ras p21 proteins Current Opinion in Genetics and Development. 4: 71-76. PMID 8193543 DOI: 10.1016/0959-437X(94)90093-0  0.56
1994 Freed E, McCormick F, Ruggieri R. Proteins of the 14-3-3 family associate with Raf and contribute to its activation Cold Spring Harbor Symposia On Quantitative Biology. 59: 187-193. PMID 7587069  0.56
1994 McCormick F. Raf: the holy grail of Ras biology? Trends in Cell Biology. 4: 347-350. DOI: 10.1016/0962-8924(94)90075-2  0.56
1994 Xu N, McCormick F, Gutkind JS. The non-catalytic domain of ras-GAP inhibits transformation induced by G protein coupled receptors Oncogene. 9.  0.56
1993 Bollag G, McCormick F, Clark R. Characterization of full-length neurofibromin: Tubulin inhibits Ras GAP activity Embo Journal. 12: 1923-1927. PMID 8491185  0.56
1993 Polakis P, McCormick F. Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target Journal of Biological Chemistry. 268: 9157-9160. PMID 8486615  0.56
1993 McCormick F. The GTPase superfamily. Introduction Ciba Foundation Symposium. 176: 1-5. PMID 8299413  0.56
1993 Boguski MS, McCormick F. Proteins regulating Ras and its relatives Nature. 366: 643-654. PMID 8259209  0.56
1993 Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science (New York, N.Y.). 262: 1069-72. PMID 7694367  0.56
1993 McCormick F. How receptors turn Ras on Nature. 362: 15-16.  0.56
1992 Polakis P, Rubinfeld B, McCormick F. Phosphorylation of rap1GAP in vivo and by cAMP-dependent kinase and the cell cycle p34cdc2 kinase in vitro Journal of Biological Chemistry. 267: 10780-10785. PMID 1587853  0.56
1992 Bollag G, McCormick F. NF is enough of GAP Nature. 356: 663-664. PMID 1570011  0.56
1992 Cichowski K, McCormick F, Brugge JS. p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets Journal of Biological Chemistry. 267: 5025-5028. PMID 1544885  0.56
1992 Bollag G, McCormick F. GTPase activating proteins Seminars in Cancer Biology. 3: 199-208. PMID 1421164  0.56
1992 Polakis P, McCormick F. Interactions between p21(ras) proteins and their GTPase activating proteins Cancer Surveys. 12: 25-42. PMID 1386285  0.56
1992 McCormick F. Coupling of ras p21 signalling and GTP hydrolysis by GTPase activating proteins Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 336: 43-47; discussion 47. PMID 1351295  0.56
1991 Bollag G, McCormick F. Differential regulation of rasGAP and neurofibromatosis gene product activities Nature. 351: 576-579. PMID 1904555  0.56
1991 Han JW, Mccormick F, Macara IG. Regulation of Ras-GAP and the neurofibromatosis-1 gene product by eicosanoids Science. 252: 576-579. PMID 1902323  0.56
1991 Koeffler HP, McCormick F, Denny C. Molecular mechanisms of cancer Western Journal of Medicine. 155: 505-514. PMID 1815390  0.56
1991 McCormick F. Brief report. GTP-binding proteins as oncogenes in human tumors Environmental Health Perspectives. 93: 17-18. PMID 1773789  0.56
1991 Haubruck H, McCormick F. Ras p21: effects and regulation Bba - Reviews On Cancer. 1072: 215-229. PMID 1751548 DOI: 10.1016/0304-419X(91)90015-D  0.56
1991 Bollag G, McCormick F. Regulators and effectors of ras proteins Annual Review of Cell Biology. 7: 601-632. PMID 1667084  0.56
1991 Ruggieri R, McCormick F. Ras and the awd couple Nature. 353: 390-391. PMID 1654523  0.56
1991 Bollag G, Haubruck H, McCormick F. Chapter 26. Regulation of the ras GTPase Cycle Annual Reports in Medicinal Chemistry. 26: 249-258. DOI: 10.1016/S0065-7743(08)61213-0  0.56
1990 McCormick F. GAP as ras effector or negative regulator? Molecular Carcinogenesis. 3: 185-187. PMID 2206281  0.56
1990 Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: a conserved switch for diverse cell functions. Nature. 348: 125-32. PMID 2122258 DOI: 10.1038/348125a0  0.56
1990 McCormick F. The world according to GAP Oncogene. 5: 1281-1283. PMID 1699195  0.56
1989 McCormick F. The polymerase chain reaction and cancer diagnosis Cancer Cells. 1: 56-61. PMID 2561871  0.56
1989 McCormick F. Ras GTPase activating protein: Signal transmitter and signal terminator Cell. 56: 5-8. PMID 2535967  0.56
1989 McCormick F. Gasp: not just another oncogene Nature. 340: 678-679. PMID 2505083  0.56
1988 Weaver JF, McCormick F, Manos MM. Production of recombinant human csf-1 in an inducible mammalian expression system Bio/Technology. 6: 287-290. DOI: 10.1038/nbt0388-287  0.56
1987 Trahey M, McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants Science. 238: 542-545. PMID 2821624  0.56
1986 Innis MA, McCormick F. Procedures for expression, modification, and analysis of human fibroblast interferon (IFN-β) genes in heterologous cells Methods in Enzymology. 397-403.  0.56
1985 Aldwin L, Nitecki D, McCormick F. A novel agent for coupling synthetic peptides to carriers for immunogen production and its application in producing antibodies to oncogene protein Federation Proceedings. 44.  0.56
1980 McCormick F, Harlow E. Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. Journal of Virology. 34: 213-24. PMID 6246255  0.56
Show low-probability matches.